Pioneer work by Prof. Cossart among others, studying the interactions between pathogenic bacteria and host cells (this discipline was termed Cellular Microbiology), was fundamental to determine the bacterial infection processes and to improve our knowledge of different cellular mechanisms.
The study of bacteria-host interactions also involves in vivo host immune responses, which can be manipulated by bacteria, being these last potent tools for different immunotherapies.
During the last years, tumour immunotherapies, mainly the use of antibodies that target immune checkpoints [checkpoint inhibitors (CPI)], have been a revolution in oncology, allowing the treatment of tumours otherwise with very bad prognosis. In the same direction, bacteria inoculations have been used from long to treat some cancers; for example, non-muscle-invasive bladder cancer can be successfully treated with the bacterium Bacillus Calmette Guerin (BCG).
AKR/12B-2 |
|||
| ABC-TC205S | AcceGen | 1 vial | Ask for price |
|
Description: Tissue: thymus; Transformed by: X-rays. The cells express Lyt-2, Lyt-3 and CD4 in the cytosol, but not on the membrane; They reexpress Lyt-2, Lyt-3 and CD4 on the membrane after sorting by magnetic particles (5 cycles). |
|||
AKR/12B-3 |
|||
| ABC-TC206S | AcceGen | 1 vial | Ask for price |
|
Description: Tissue: thymus; Transformed by: X-rays. The cells express Lyt-2, Lyt-3 and CD4 in the cytosol, but not on the membrane; They do not reexpress Lyt-2, Lyt-3 and CD4 on the membrane after sorting by magnetic particles (5 cycles). |
|||
Ala-Lys-Arg (AKR) |
|||
| 070-06 | PHOENIX PEPTIDE | 5 mg | EUR 102.6 |
Recombinant Chicken Homeobox protein AKR |
|||
| MBS1464784-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1150 |
Recombinant Chicken Homeobox protein AKR |
|||
| MBS1464784-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 785 |
Recombinant Chicken Homeobox protein AKR |
|||
| MBS1464784-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 940 |
Recombinant Chicken Homeobox protein AKR |
|||
| MBS1464784-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 940 |
Recombinant Chicken Homeobox protein AKR |
|||
| MBS1464784-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1100 |
Recombinant Neurospora crassa Palmitoyltransferase AKR1 (akr-1) |
|||
| MBS7007634-002mg | MyBiosource | 0.02mg | EUR 2125 |
Recombinant Neurospora crassa Palmitoyltransferase AKR1 (akr-1) |
|||
| MBS7007634-01mg | MyBiosource | 0.1mg | EUR 3050 |
Recombinant Neurospora crassa Palmitoyltransferase AKR1 (akr-1) |
|||
| MBS7007634-5x01mg | MyBiosource | 5x0.1mg | EUR 13680 |
Recombinant Neurospora crassa Palmitoyltransferase AKR1 (akr-1), partial |
|||
| MBS7087629-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Mouse Esophageal Cancer Cell Line-AKR |
|||
| CC7F9 | BioVenic | 1x 10^6 Cells/Vial | Ask for price |
Rabbit anti-AKV murine leukemia virus (AKR (endogenous) murine leukemia virus) POL Polyclonal Antibody |
|||
| MBS7161921-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-AKV murine leukemia virus (AKR (endogenous) murine leukemia virus) env Polyclonal Antibody |
|||
| MBS7161930-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-AKV murine leukemia virus (AKR (endogenous) murine leukemia virus) GAG Polyclonal Antibody |
|||
| MBS7166574-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Mouse Esophageal Cancer Cell Line-AKR-GFP-Puro |
|||
| CC9F71 | BioVenic | 1x 10^6 Cells/Vial | Ask for price |
GIBH-130 |
|||
| 555149 | MedKoo Biosciences | 10.0mg | EUR 150 |
MSX-130 |
|||
| 555221 | MedKoo Biosciences | 10.0mg | EUR 150 |
AT-130 |
|||
| 530587 | MedKoo Biosciences | 5.0mg | EUR 350 |
AH-130 |
|||
| ABC-TC0040 | AcceGen | 1 vial | Ask for price |
|
Description: Established in vitro from the AH-130 tumor-ascites, RAP-Test negative The species was confirmed by Real-Time PCR. |
|||
GIBH-130 |
|||
| B2071-25 | Biovision | each | EUR 907.2 |
GIBH-130 |
|||
| B2071-5 | Biovision | each | EUR 274.8 |
HA 130 |
|||
| B1192-25 | Biovision | each | EUR 496.8 |
HA 130 |
|||
| B7612-10 | ApexBio | 10 mg | EUR 109.6 |
|
Description: Others|Autotaxin |
|||
HA 130 |
|||
| B7612-100 | ApexBio | 100mg | EUR 992 |
|
Description: Others|Autotaxin |
|||
HA 130 |
|||
| B7612-25 | ApexBio | 25 mg | EUR 289.2 |
HA 130 |
|||
| B7612-5 | ApexBio | 5 mg | EUR 132.8 |
|
Description: Others|Autotaxin |
|||
HA 130 |
|||
| B7612-50 | ApexBio | 50mg | EUR 328.8 |
|
Description: Others|Autotaxin |
|||
HA-130 |
|||
| MBS130680-100mg | MyBiosource | 100mg | EUR 1065 |
HA-130 |
|||
| MBS130680-500mg | MyBiosource | 500mg | EUR 2775 |
AT-130 |
|||
| HY-100028 | MedChemExpress | 10 mg | EUR 1136.38 |
|
Description: AT-130, a phenylpropenamide derivative, is a potent hepatitis B virus (HBV) replication non-nucleoside inhibitor. AT-130 inhibits the viral DNA synthesis with an EC50 of 0.13 μM. AT-130 inhibits both wt and mutant HBVs. AT-130 has anti-HBV activity in hepatoma cells[1][2][3]. |
|||
GIBH-130 |
|||
| HY-101860 | MedChemExpress | 10mM/1mL | EUR 746.76 |
|
Description: GIBH-130 is an effective inhibitor of neuroinflammation. GIBH-130 significantly suppresses the IL-1β secretion by activated microglia (IC50=3.4 nM). |
|||
MSX-130 |
|||
| HY-103010 | MedChemExpress | 1 mg | EUR 725.12 |
|
Description: MSX-130 is a CXCR4 antagonist. MSX-130 inhibits cancer metastasis[1]. |
|||
CAL-130 |
|||
| HY-16122A | MedChemExpress | 5mg | EUR 424.8 |
|
Description: CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively. |
|||
HA-130 |
|||
| MBS3600904-10mg | MyBiosource | 10mg | EUR 270 |
HA-130 |
|||
| MBS3600904-25mg | MyBiosource | 25mg | EUR 350 |
HA-130 |
|||
| MBS3600904-2mg | MyBiosource | 2mg | EUR 200 |
HA-130 |
|||
| MBS3600904-50mg | MyBiosource | 50mg | EUR 480 |
HA-130 |
|||
| MBS3600904-5mg | MyBiosource | 5mg | EUR 240 |
GIBH-130 |
|||
| MBS3601012-10mg | MyBiosource | 10mg | EUR 340 |
GIBH-130 |
|||
| MBS3601012-25mg | MyBiosource | 25mg | EUR 475 |
GIBH-130 |
|||
| MBS3601012-2mg | MyBiosource | 2mg | EUR 230 |
GIBH-130 |
|||
| MBS3601012-50mg | MyBiosource | 50mg | EUR 730 |
GIBH-130 |
|||
| MBS3601012-5mg | MyBiosource | 5mg | EUR 275 |
CAL-130 |
|||
| MBS3840786-10mg | MyBiosource | 10mg | EUR 405 |
CAL-130 |
|||
| MBS3840786-50mg | MyBiosource | 50mg | EUR 925 |
CAL-130 |
|||
| MBS3840786-5mg | MyBiosource | 5mg | EUR 310 |
CAL-130 |
|||
| MBS3840786-5x50mg | MyBiosource | 5x50mg | EUR 4160 |
MSX-130 |
|||
| MBS3607496-10mg | MyBiosource | 10mg | EUR 380 |
MSX-130 |
|||
| MBS3607496-25mg | MyBiosource | 25mg | EUR 575 |
MSX-130 |
|||
| MBS3607496-2mg | MyBiosource | 2mg | EUR 285 |
MSX-130 |
|||
| MBS3607496-50mg | MyBiosource | 50mg | EUR 730 |
MSX-130 |
|||
| MBS3607496-5mg | MyBiosource | 5mg | EUR 325 |
GIBH-130 |
|||
| MBS3842799-10mg | MyBiosource | 10mg | EUR 345 |
GIBH-130 |
|||
| MBS3842799-2mg | MyBiosource | 2mg | EUR 180 |
GIBH-130 |
|||
| MBS3842799-50mg | MyBiosource | 50mg | EUR 985 |
GIBH-130 |
|||
| MBS3842799-5mg | MyBiosource | 5mg | EUR 245 |
GIBH-130 |
|||
| MBS3842799-5x50mg | MyBiosource | 5x50mg | EUR 4420 |
MSX-130 |
|||
| MBS3842125-100mg | MyBiosource | 100mg | EUR 1765 |
MSX-130 |
|||
| MBS3842125-10mg | MyBiosource | 10mg | EUR 290 |
MSX-130 |
|||
| MBS3842125-50mg | MyBiosource | 50mg | EUR 960 |
MSX-130 |
|||
| MBS3842125-5mg | MyBiosource | 5mg | EUR 210 |
MSX-130 |
|||
| MBS3842125-5x100mg | MyBiosource | 5x100mg | EUR 7940 |
GIBH-130 |
|||
| MBS5750563-10mg | MyBiosource | 10mg | EUR 225 |
GIBH-130 |
|||
| MBS5750563-25mg | MyBiosource | 25mg | EUR 370 |
GIBH-130 |
|||
| MBS5750563-2mg | MyBiosource | 2mg | EUR 155 |
GIBH-130 |
|||
| MBS5750563-50mg | MyBiosource | 50mg | EUR 560 |
GIBH-130 |
|||
| MBS5750563-5mg | MyBiosource | 5mg | EUR 175 |
AT-130 |
|||
| MBS5764862-10mg | MyBiosource | 10mg | EUR 395 |
AT-130 |
|||
| MBS5764862-1mg | MyBiosource | 1mg | EUR 175 |
AT-130 |
|||
| MBS5764862-25mg | MyBiosource | 25mg | EUR 565 |
AT-130 |
|||
| MBS5764862-50mg | MyBiosource | 50mg | EUR 810 |
AT-130 |
|||
| MBS5764862-5mg | MyBiosource | 5mg | EUR 245 |
CAL-130 |
|||
| MBS5766259-5mg | MyBiosource | 5mg | EUR 915 |
CAL-130 |
|||
| MBS5766259-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
MSX-130 |
|||
| MBS579938-10mg | MyBiosource | 10mg | EUR 240 |
MSX-130 |
|||
| MBS579938-1mg | MyBiosource | 1mg | EUR 150 |
MSX-130 |
|||
| MBS579938-25mg | MyBiosource | 25mg | EUR 380 |
MSX-130 |
|||
| MBS579938-2mg | MyBiosource | 2mg | EUR 175 |
MSX-130 |
|||
| MBS579938-5mg | MyBiosource | 5mg | EUR 190 |
PK 130 |
|||
| MBS5783607-5mg | MyBiosource | 5(mg | EUR 915 |
PK 130 |
|||
| MBS5783607-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
LP 130 |
|||
| MBS5774169-5mg | MyBiosource | 5(mg | EUR 915 |
LP 130 |
|||
| MBS5774169-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
G-130 |
|||
| MBS5777105-5mg | MyBiosource | 5(mg | EUR 915 |
G-130 |
|||
| MBS5777105-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
PK 130 |
|||
| T34083-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: PK 130 |
|||
PK 130 |
|||
| T34083-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: PK 130 |
|||
PK 130 |
|||
| T34083-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: PK 130 |
|||
PK 130 |
|||
| T34083-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: PK 130 |
|||
PK 130 |
|||
| T34083-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: PK 130 |
|||
AT-130 |
|||
| T26674-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: AT-130 |
|||
AT-130 |
|||
| T26674-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: AT-130 |
|||
AT-130 |
|||
| T26674-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: AT-130 |
|||
AT-130 |
|||
| T26674-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: AT-130 |
|||
AT-130 |
|||
| T26674-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: AT-130 |
|||
G-130 |
|||
| T27396-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: G-130 |
|||
G-130 |
|||
| T27396-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: G-130 |
|||
G-130 |
|||
| T27396-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: G-130 |
|||
G-130 |
|||
| T27396-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: G-130 |
|||
G-130 |
|||
| T27396-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: G-130 |
|||
LP 130 |
|||
| T24416-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: LP 130 |
|||
LP 130 |
|||
| T24416-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: LP 130 |
|||
LP 130 |
|||
| T24416-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: LP 130 |
|||
LP 130 |
|||
| T24416-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: LP 130 |
|||
LP 130 |
|||
| T24416-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: LP 130 |
|||
CAL-130 |
|||
| T10660-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CAL-130 |
|||
CAL-130 |
|||
| T10660-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CAL-130 |
|||
CAL-130 |
|||
| T10660-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CAL-130 |
|||
CAL-130 |
|||
| T10660-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CAL-130 |
|||
CAL-130 |
|||
| T10660-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CAL-130 |
|||
MSX-130 |
|||
| T4033-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: MSX-130 |
|||
MSX-130 |
|||
| T4033-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: MSX-130 |
|||
MSX-130 |
|||
| T4033-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: MSX-130 |
|||
MSX-130 |
|||
| T4033-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: MSX-130 |
|||
MSX-130 |
|||
| T4033-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: MSX-130 |
|||
GIBH-130 |
|||
| T4450-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GIBH-130 |
|||
GIBH-130 |
|||
| T4450-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GIBH-130 |
|||
GIBH-130 |
|||
| T4450-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GIBH-130 |
|||
GIBH-130 |
|||
| T4450-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GIBH-130 |
|||
GIBH-130 |
|||
| T4450-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GIBH-130 |
|||
Lenti ORF particles, AKR1C3 (Myc-DDK tagged) - Human aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR |
|||
| RC200210L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, AKR1C3 (Myc-DDK tagged) - Human aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR |
|||
| RC200210L3V | Origene Technologies GmbH | 200 µl | Ask for price |
STF 210-130*130-B7527 AC Signs |
|||
| 222596 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - ARRÊT D'URGENCE; Description French: Pictogramme sécurité incendie - Arrêt d’urgence |
|||
STF 211-130*130-B7527 AC Signs |
|||
| 222598 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - CLES CABINE; Description French: Pictogramme sécurité incendie - Clés cabine |
|||
STF 212-130*130-B7527 AC Signs |
|||
| 222600 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - COUPURE D'URGENCE; Description French: Pictogramme sécurité incendie - Coupure d’urgence |
|||
STF 210-130*130-B7541 AC Signs |
|||
| 222832 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - ARRÊT D'URGENCE; Description French: Pictogramme sécurité incendie - Arrêt d’urgence |
|||
STF 211-130*130-B7541 AC Signs |
|||
| 222833 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - CLES CABINE; Description French: Pictogramme sécurité incendie - Clés cabine |
|||
STF 212-130*130-B7541 AC Signs |
|||
| 222834 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
|
Description: Description Dutch: Pictogram voor Brandbestrijding - COUPURE D'URGENCE; Description French: Pictogramme sécurité incendie - Coupure d’urgence |
|||
Musclin (105-130) / Osteocrin (Ostn) (105-130) (Mouse) |
|||
| 028-67 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) |
|||
| 028-69 | PHOENIX PEPTIDE | 100 μg | EUR 355.32 |
CAL-130 Hydrochloride |
|||
| A3268-10 | ApexBio | 10 mg | EUR 454.4 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
|||
CAL-130 Hydrochloride |
|||
| A3268-2 | ApexBio | 2mg | EUR 234.4 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
|||
CAL-130 Hydrochloride |
|||
| A3268-5 | ApexBio | 5 mg | EUR 352 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
|||
CAL-130 Hydrochloride |
|||
| A3268-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 584.4 |
|
Description: Class I phosphoinositide 3-kinase (PI3K) activate fundamental pathways controlling cell survival, metabolism, proliferation and and therefore play crucial role in cancer development. |
|||
CAL-130 Hydrochloride |
|||
| A3268-50 | ApexBio | 50 mg | EUR 1226.4 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
|||
AH-130 FN |
|||
| ABC-TC0041 | AcceGen | 1 vial | Ask for price |
|
Description: Established in vitro from the AH-130 FN tumor ascites (Cell Lines Service), RAP-Test negativ The species was confirmed by Real-Time PCR. |
|||
nhr-130 Antibody |
|||
| CSB-PA522706XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-130 protein |
|||
nhr-130 Antibody |
|||
| CSB-PA522706XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-130 protein |
|||
IL16, (130 a.a.) |
|||
| cyt-536 | ProSpec Tany | 2µg | EUR 60 |
|
Description: Recombinant Human Interleukin-16, (130 a.a.) |
|||
Anticancer agent 130 |
|||
| HY-149890 | MedChemExpress | Get quote | Ask for price |
|
Description: Anticancer agent 130 (compound 8d) is an anticancer agent that can significantly induce apoptosis in A549 cells[1]. |
|||
Antibacterial agent 130 |
|||
| HY-152175 | MedChemExpress | Get quote | Ask for price |
|
Description: Antibacterial agent 130 is a 1,1-diarylthiogalactoside, used for targeting the Pseudomonas aeruginosa LecA. Antibacterial agent 130 shows high affinity toward LecA (Kd=1 μM). Antibacterial agent 130 has antibiofilm activity, but lacks bactericidal activity. LecA, a lectin and virulence factor from Pseudomonas aeruginosa involved in bacterial adhesion and biofilm formation[1]. |
|||
CAL-130 (Racemate) |
|||
| HY-16122 | MedChemExpress | 50mg | EUR 1706.4 |
|
Description: CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor. |
|||
CAL-130 (Hydrochloride) |
|||
| HY-16122B | MedChemExpress | 5mg | EUR 1293.31 |
|
Description: CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively. |
|||
Antitumor agent-130 |
|||
| HY-162128 | MedChemExpress | Get quote | Ask for price |
|
Description: Antitumor agent-130 (Compound 7b) is a p300 histone acetyltransferases (HAT) inhibitor with an IC50 of 1.51 μM. Antitumor agent-130 combinates with doxorubicin (HY-15142A) can significantly inhibit tumor growth and invasion in vitro and in vivo[1]. |
|||
ZXH-4-130 |
|||
| HY-132857 | MedChemExpress | Get quote | Ask for price |
|
Description: ZXH-4-130 is a highly potent and selective degrader of CRBN. ZXH-4-130 is a CRBN-VHL compound (hetero-PROTAC)[1]. |
|||
AC-4-130 |
|||
| HY-124500 | MedChemExpress | 10 mg | EUR 1406.95 |
|
Description: AC-4-130 is a potent STAT5 SH2 domain inhibitor. AC-4-130 directly binds to STAT5 and disrupts STAT5 activation, dimerization, nuclear translocation, and STAT5-dependent gene transcription. AC-4-130 induces cell cycle arrest and apoptosis in FLT3-ITD-driven leukemic cells. AC-4-130 has anti-cancer activity and can efficiently block pathological levels of STAT5 activity in acute myeloid leukemia (AML)[1]. |
|||
CAL-130 Hydrochloride |
|||
| MBS3840787-10mg | MyBiosource | 10mg | EUR 405 |
CAL-130 Hydrochloride |
|||
| MBS3840787-50mg | MyBiosource | 50mg | EUR 925 |
CAL-130 Hydrochloride |
|||
| MBS3840787-5mg | MyBiosource | 5mg | EUR 310 |
CAL-130 Hydrochloride |
|||
| MBS3840787-5x50mg | MyBiosource | 5x50mg | EUR 4160 |
CAL-130 Racemate |
|||
| MBS3845378-10mg | MyBiosource | 10mg | EUR 1905 |
CAL-130 Racemate |
|||
| MBS3845378-1mg | MyBiosource | 1mg | EUR 430 |
CAL-130 Racemate |
|||
| MBS3845378-5mg | MyBiosource | 5mg | EUR 1165 |
CAL-130 Racemate |
|||
| MBS3845378-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
AC-4-130 |
|||
| MBS3842780-10mg | MyBiosource | 10mg | EUR 1210 |
AC-4-130 |
|||
| MBS3842780-50mg | MyBiosource | 50mg | EUR 4080 |
AC-4-130 |
|||
| MBS3842780-5mg | MyBiosource | 5mg | EUR 690 |
AC-4-130 |
|||
| MBS3842780-5x50mg | MyBiosource | 5x50mg | EUR 18350 |
CAL-130 Hydrochloride |
|||
| MBS5752847-50mg | MyBiosource | 50mg | EUR 1095 |
CAL-130 Hydrochloride |
|||
| MBS5752847-5x50mg | MyBiosource | 5x50mg | EUR 4785 |
AC-4-130 |
|||
| MBS5784895-10mg | MyBiosource | 10mg | EUR 375 |
AC-4-130 |
|||
| MBS5784895-25mg | MyBiosource | 25mg | EUR 675 |
AC-4-130 |
|||
| MBS5784895-50mg | MyBiosource | 50mg | EUR 1515 |
AC-4-130 |
|||
| MBS5784895-5mg | MyBiosource | 5(mg | EUR 280 |
ZXH-4-130 |
|||
| MBS5800596-5mg | MyBiosource | 5(mg | EUR 915 |
ZXH-4-130 |
|||
| MBS5800596-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
CAL-130 Racemate |
|||
| MBS5789795-5mg | MyBiosource | 5(mg | EUR 915 |
CAL-130 Racemate |
|||
| MBS5789795-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
AC-4-130 |
|||
| T35429-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: AC-4-130 |
|||
AC-4-130 |
|||
| T35429-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: AC-4-130 |
|||
AC-4-130 |
|||
| T35429-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: AC-4-130 |
|||
AC-4-130 |
|||
| T35429-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: AC-4-130 |
|||
AC-4-130 |
|||
| T35429-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: AC-4-130 |
|||
CAL-130 Hydrochloride |
|||
| T10660L-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CAL-130 Hydrochloride |
|||
CAL-130 Hydrochloride |
|||
| T10660L-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CAL-130 Hydrochloride |
|||
CAL-130 Hydrochloride |
|||
| T10660L-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CAL-130 Hydrochloride |
|||
CAL-130 Hydrochloride |
|||
| T10660L-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CAL-130 Hydrochloride |
|||
CAL-130 Hydrochloride |
|||
| T10660L-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CAL-130 Hydrochloride |
|||
CAL-130 Racemate |
|||
| T10660L2-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: CAL-130 Racemate |
|||
CAL-130 Racemate |
|||
| T10660L2-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: CAL-130 Racemate |
|||
CAL-130 Racemate |
|||
| T10660L2-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: CAL-130 Racemate |
|||
CAL-130 Racemate |
|||
| T10660L2-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: CAL-130 Racemate |
|||
CAL-130 Racemate |
|||
| T10660L2-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: CAL-130 Racemate |
|||
ZXH-4-130 |
|||
| T40332-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ZXH-4-130 |
|||
ZXH-4-130 |
|||
| T40332-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ZXH-4-130 |
|||
ZXH-4-130 |
|||
| T40332-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ZXH-4-130 |
|||
ZXH-4-130 |
|||
| T40332-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ZXH-4-130 |
|||
ZXH-4-130 |
|||
| T40332-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ZXH-4-130 |
|||
